Yet, the results of different studies are not consistent, and Paköz et al. did not find any difference in hepcidin-25 levels between patients with active IBD and those in remission; neither detected a link between hepcidin-25 and inflammatory markers CRP and IL-6 in IBD patients [13]. This evidence concerns the gene IL6 and inflammatory bowel disease.